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Background: Sarcopenia, a progressive age-related loss of skeletal muscle mass and strength, leads to
disability, falls, and hospitalisation. Individual variation in sarcopenia onset may be partly explained by
lifestyle factors such as physical activity and diet. Healthy dietary patterns (DPs) have been linked to better
physical functioning in older adults, but their role in sarcopenia in the very old (aged 85) is unknown.
Aims: To investigate the association between DPs and the risk of sarcopenia over 3 years, and to
determine whether protein intake influences this relationship in community-dwelling older adults from
the Newcastle 85 þ Study.
Methods: The analytic sample consisted of 757 participants (61.2% women) who had dietary assessment
at baseline. After two-step clustering with 30 food groups to derive DPs, we used logistic regression to
determine the risk of prevalent and incident sarcopenia across DPs in all participants, and in those with
low (<1 g/kg adjusted body weight/day [g/kg aBW/d]) and good protein intake (1 g/kg aBW/d).
Results: We identified three DPs (DP1: ‘Low RedMeat’, DP2: ‘Traditional British’ and DP3: ‘Low Butter’) that
varied by unsaturated fat spreads/oils, butter, red meat, gravy and potato consumption. Compared with
participants in DP3, those in DP2 had an increased risk of prevalent (OR¼ 2.42, 95% CI: 1.15e5.09, p¼ 0.02)
but not 3-year incident sarcopenia (OR ¼ 1.67, 0.59e4.67, p ¼ 0.33) adjusted for socio-demographic,
anthropometry, health and lifestyle factors. Furthermore, DP2 was associated with an increased risk of
prevalent sarcopenia at baseline (OR ¼ 2.14, 1.01e4.53, p ¼ 0.05) and 3-year follow-up (OR ¼ 5.45, 1.81
e16.39, p ¼ 0.003) after adjustment for key covariates in participants with good protein intake.
Conclusion: A DP high in foods characteristic of a traditional British diet (butter, red meat, gravy and
potato) was associated with an increased risk of sarcopenia even when overall protein intake was good.
The results need to be replicated in other cohorts of the very old to understand the role of DPs in
sarcopenia onset and management.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
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The European Working Group on Sarcopenia in Older Adults
(EWGSOP) defines sarcopenia as a progressive and generalised age-
related loss of muscle mass and strength [1], which starts in the
fifth decade of life and increases in prevalence to ~12.5e50.0% in
older adults aged >80 [2e5]. Clinically, sarcopenia is linked with
numerous adverse health events including osteoporosis, diabetes,
and obesity [6e9], and strongly associated with frailty, risk of falls,le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Flowchart of participants in the Newcastle 85 þ Study. At baseline, 757
participants (89.6% of sample with complete multidimensional health assessment
and GP records review) had dietary assessments (2  24-h multiple pass dietary
recall) and lived in the community (analytic sample). Of those, 702 (83.1%) had
complete data to establish sarcopenia (i.e. grip strength or gait speed, and muscle
mass) at baseline and 373 (44.1% of analytic sample) had data at follow-up 3 years
later.
A. Granic et al. / Clinical Nutrition xxx (xxxx) xxx2andmortality in mid and late adulthood [10e13]. Whilst declines in
musclemass and strength are a common features of ageing [14], the
rate of the loss varies substantially between individuals, and has
been attributed to intrinsic (e.g. hormonal changes, genetic factors)
[15] and extrinsic (environmental) factors such as physical activity
and diet [16e18].
Higher physical activity and resistance exercise are established
modifiable lifestyle factors that minimise muscle mass/strength
decline [20,21], alone or in combination with higher protein
intake (1 g/kg body weight (BW)/day) [16,22,23]. In comparison,
the role of the whole diet in sarcopenia risk has been little
researched, with some evidence linking higher intake of indi-
vidual nutrients (e.g. protein, vitamin D, n-3 polyunsaturated fatty
acids (n-3 PUFA), antioxidants) [24e28] and food groups (e.g.
meats, fruits and vegetables, dairy) [29,30] to reduced risk of
sarcopenia and better muscle function in older adults. However,
only a few studies have been conducted in the very old (aged
85) [31,32], who have higher prevalence of sarcopenia [4], and
are at increased risk of malnutrition [33], poor diet [34e36] and
inactivity [37]dthe main modifiable risk factors for loss of muscle
mass/strength.
The derivation of dietary patterns (DPs) has been successfully
used to characterise diet complexity and quality, accounting for
the synergy between foods and nutrients, and to examine the
association of DPs with various health outcomes [38,39]. Two
different approaches for assessing DPs have been used widely:
(a) dietary scores or indices which are based on the prevailing
hypotheses of what constitutes a healthy diet for disease risk
reduction (e.g. Mediterranean diet score), and (b) factors or
clusters derived using data reduction methods on available
dietary data without prior hypotheses about diet-disease rela-
tionship. A few studies have utilised these methods to investigate
associations between DPs and sarcopenia (e.g. [40e42], reviewed
in [43,44])d the Mediterranean DP has been the most common
approach and none of the studies has been conducted in the
very old.
Therefore, we aimed to: (a) derive and characterise DPs in
community-dwelling very old adults from the Newcastle 85þ Study
at baseline; (b) determine the risk of prevalent and incident sarco-
penia over 3 years in relation to DPs, and (c) explore whether the
DP-sarcopenia relationship is influenced by participants’ protein
intake.2. Materials and methods
2.1. Study design and participants
The Newcastle 85þ Study is a prospective cohort study of health
and functioning of over 1000 participants (birth cohort 1921) who
were registered with general practices in Newcastle and North
Tyneside, UK. The study has been described in detail previously
[45,46]. Briefly, participants (aged85 years) were assessed using a
comprehensive health assessment at baseline (wave 1, 2006/07),
and followed at 18 months (1.5 years; wave 2), 36 months (3 years;
wave 3), and 60 months (5 years; wave 4) by trained research
nurses at their usual place of residence. At baseline, 845 partici-
pants had a multidimensional health assessment (including muscle
mass, muscle strength, and physical performance) and general
practice records review (GPrr), and 757 (463 (61.2%) women) were
community-dwelling and had dietary intake data (i.e. analytic
sample). Of those, 702 (83.1% of analytic sample) participants had
complete data at baseline to establish their sarcopenia status based
on the EWGSOP criteria, and 373 (44.1%) participants at 3-year
follow-up (wave 3) (Fig. 1).Please cite this article as: Granic A et al., Effects of dietary patterns and low
study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2019.01.0092.2. Ethics statement
The study was approved by the Newcastle & North Tyneside
Local Research Ethics Committee 1 and in agreement with The Code
of Ethics of theWorldMedical Association (Declaration of Helsinki).
Signed consent was obtained from each participant or, where
participants lacked capacity, a signed consultee approval was
obtained prior to the study commencement.
2.3. Study variables
2.3.1. Dietary assessment
Dietary assessment and validation of 24 h multiple pass di-
etary recall (24-hr MPR) in the Newcastle 85 þ Study have been
described previously [47,48]. Briefly, a pilot study in a sub-sample
of this cohort determined that 24-hr MPR was more appropriate
for individual dietary assessment of the very old and more
accurate in estimating energy and nutrient intake compared with
the food frequency questionnaire (FFQ) [47]. At baseline (2006/
07), trained research nurses made a detailed record of foods
eaten on the previous day (e.g. type, amount and eating occasion)
for each participant on two non-consecutive days (except Fridays
and Saturdays), at least a week apart. Each food was assigned a
unique food code (>2000 codes) and intakes (in g; mean for 2
days) were entered in a Microsoft Access-based dietary data
system. Food codes were grouped into 118 food groups (based on
McCance and Widdowson's The Composition of Foods [47e49]),
and further combined into 33 food groups (based on food/
nutrient composition similarities) as described previously [48].
These were classified as absent (coded 0 if food not consumed) or
present (coded 1 if food consumed) for each participant. Thirty
food groups were used in the cluster analysis to derive DPs as
described [48].protein intake on sarcopenia risk in the very old: The Newcastle 85þ
A. Granic et al. / Clinical Nutrition xxx (xxxx) xxx 32.3.2. Protein intake categorisation
Low protein intake at baseline was defined as intake of <1 g
protein/adjusted (ideal) BW/day (<1 g/kg aBW/d) as described
previously [31,33]. This cut-off was based on previous findings from
our group showing that protein intake <1 g/kg aBW/d was associ-
ated with lower grip strength (GS) and slower performance on
Timed Up-and-Go (TUG) test [31] at baseline, whilst intake of 1 g/
kg aBW/d was associated with better disability trajectories from 85
to 90 years in this cohort [32]. For g/kg aBW/d calculations,
measured body weight was adjusted to a desirable body weight if a
participant was outside a healthy body mass index (BMI) range of
22e27 for an older adult aged 71 years (described in [50]). The
22e27 BMI range has been associated with a decreased risk of
mortality, and led to higher estimates of protein inadequacy in
those aged 71 years [50]. The aBW was then used to establish
protein intake cut-offs (low [<1 g/kg aBW/d] versus good [1 g/kg
aBW/d]) in 722 participants (of whom 56.1% had BW adjusted to
healthy BMI) [31e33]. As a sensitivity analysis, we re-fitted the
models using protein intake dichotomised to< and0.8 g/kg actual
BW/d and < and 1.0 g/kg actual BW/d cut-offs.
2.3.3. EWGSOP definition of sarcopenia
Prevalence (wave 1 and wave 3) and incidence of sarcopenia
(wave 3) in this cohort have been established previously [4] using
the EWGSOP definition [1]. Briefly, we used the following criteria
and the EWGSOP algorithm: (a) low skeletal muscle index (SMI;
skeletal muscle mass divided by height square, kg/m2) based on
previously established cut-offs (<8.87 kg/m2 in men, and <6.67 kg/
m2 in women) [51], and either (b) slow gait speed (0.8 m/s) or (c)
weak GS (<16 kg in women, and <26 kg in men) [52].
GS (kg) was measured twice in each hand using a Takei A5401
digital dynamometer (Takei Scientific Instruments Ltd., Niigata,
Japan) in the standing position. The maximum GS was used for an-
alyses. To estimate gait speed (m/s), we used the following formula
to convert the TUG) test times: 6/[TUG time]) * 1.62. The TUG test
measured the time needed to get up from a chair andwalk as quickly
and safely as possible 3m in a straight line up to amarked spot on the
floor, turn around, walk back and sit back on the chair. Body
composition, includingmusclemass, was estimatedwith the Tanita-
305 bioimpedance inbuilt algorithm (Tanita Corp., Tokyo, Japan).
2.3.4. Other covariates and potential risk factors of sarcopenia
We considered the following potential risk factors (assessed at
baseline) for sarcopenia which were previously identified in this
cohort [4,53] and regarded as clinically important. Socio-
demographic factors included: (a) sex; (b) social class (higher
managerial and administrative/intermediate/manual and routine
occupations) coded to the National Statistics Socio-economic Clas-
sification System (NS-SEC), and (c) education (0e9/10e11/12
years full-time). Anthropometry and health-related factors were:
(a) BMI (kg weight/m2 height; underweight [<18.5]/normal
[>18.5e25]/overweight and obese [>25]); (b) cognitive status
(impaired [<26 points on the Standardised Mini Mental State Ex-
amination, SMMSE]/normal [26 points on SMMSE]); (c) depres-
sive symptoms (none [score 0e5]/mild or moderate [score 6e7]/
severe [score 8e15] assessed by the Geriatric Depression Scale
(GDS-15); (d) total number of chronic diseases reported from the
GPrr (0e1/2/3), and (e) total number of medications (0e2/3e4/
5). Lifestyle factors included: (a) physical activity (low [score
0e1]/moderate [score 2e6]/high [score 7e18]); (b) smoking (never
smoker/current smoker/former smoker), and (c) total energy from
foods (continuous; kJ).
Self-reported physical activity was assessed with a purpose-
designed physical activity questionnaire which measured the fre-
quency and intensity of highly energetic, moderately energetic, andPlease cite this article as: Granic A et al., Effects of dietary patterns and low
study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2019.01.009mildly energetic activities during daily life as described previously
[45,54]. Objectively measured physical activity (actigraphy) corre-
lated well with the physical activity scores in wave 3 [54]. Chronic
diseases included cardiovascular disease (hypertension, cardiac
disease, cerebrovascular diseases), respiratory diseases, diabetes,
arthritis, and cancer [46].
In sensitivity (multivariable) analyses, retention (completed the
study/dropped out [by withdrawal or death]) was included as a
covariate to account for the ‘healthy survivor effect’. Death data
were obtained through the NHS Digital (previously Health and
Social Care Information Service UK). BMI (kg/m2) was also cat-
egorised as <22/22e27/>27 with the middle category as a ‘normal’
BMI for older adults aged 71 years [50].
2.4. Statistical analysis
2.4.1. Derivation of DP
Derivation of DP have been described in detail previously
[48,53] and summarised in the Supplementary Information
(Appendix 1).
2.4.2. Descriptive statistics
Participants were compared on key sociodemographic, anthro-
pometric, health-related, lifestyle, dietary, and nutritional variables
by DP using ANOVA (with post-hoc Tukey HDS or Games-Howell)
for normally distributed data, KruskaleWallis for non-normally
distributed and ordinal data, and the Chi-square test for categori-
cal variables.
2.4.3. Multivariable analysis
We fitted several logistic regression models to explore the
association between DP and prevalent sarcopenia (at baseline and
at 3-year follow-up) and 3-year incident sarcopenia in all partici-
pants and when stratified by protein intake (low [<1 g/kg aBW/d]
versus good [1 g/kg aBW/d]) (OR 95% CI).
Model 1 was unadjusted. Model 2 was adjusted for socio-
demographic factors (sex, education, and social class) and BMI (in
all participants but not in stratified analysis). Model 3 was addi-
tionally adjusted for health-related factors (cognitive status,
depressive symptoms, total number of diseases and medication).
Model 4 was further adjusted for lifestyle factors (physical activity,
smoking, and food energy intake).
2.4.4. Sensitivity analysis
Model 4 was additionally adjusted for retention (completing the
study or not) to account for any survivor effect (i.e. healthier and
more robust individuals affecting the associations). We observed
that participants who completed all four waves of the study had
less chronic diseases, including cognitive impairment and sarco-
penia, lower intake of medication, higher self-rated health, fewer
disabilities, higher muscle strength and walking speed compared
with those whowere lost to follow-up (details not shown). We also
explored whether a protein intake and physical activity interaction
term influenced the association between DPs and prevalent sar-
copenia in all participants, and repeated the models with re-
categorised BMI (22e27 kg/m2 as normal/ideal category for older
adults aged 71 years). Finally, we dichotomised protein intake by
0.8 and 1 g/kg actual BW/day to examine the robustness of the
findings obtained in the main analysis with 0.8 and 1 g/kg aBW/d.
We further hypothesised that participants who died between
wave 2 (1.5-year follow-up) and wave 3 (3-year follow-up) were at
higher risk of sarcopenia (i.e. experiencing terminal decline) than
those who were alive. Therefore, in sensitivity analysis, we com-
bined incident cases of sarcopenia at 3-year follow-up with thoseprotein intake on sarcopenia risk in the very old: The Newcastle 85þ
A. Granic et al. / Clinical Nutrition xxx (xxxx) xxx4who died between wave 2 and 3, and repeated the models (in all
participants, and stratified by protein intake).
Multicollinearity of covariates was assessed by multicollinearity
diagnostics (i.e. Tolerance, Eigenvalues and Condition Index). All
analyses were conducted using IBM SPSS (V.21; IBM Corporation,
Armonk, NY, USA), and statistics were 2-sided at a ¼ 0.05.
3. Results
DPs in the Newcastle 85 þ Study participants have been
described in detail previously with the entire cohort, including
those in care homes [48,53]. DP differentiation, nutritional, socio-
demographic and health characteristics of the present analyses in
community-dwelling older adults were very similar to those pre-
viously reported in a bigger sample, and they are described in
Appendix 1.
3.1. Sarcopenia status by dietary patterns
Table 1 describes the prevalence and incidence of sarcopenia by
DPs. At baseline, DP2 (‘Traditional British’) was associated with a
greater likelihood of sarcopenia compared with other DPs, though
this did not reach statistical significance (p ¼ 0.07). Participants
belonging to DP3 (‘Low Butter’) were the least likely to have sar-
copenia at 3-year follow-up (p ¼ 0.009).
3.2. Dietary patterns, prevalent sarcopenia (at baseline and 3-year
follow-up) and 3-year incident sarcopenia in all participants
At baseline, 145 participants (19.2% of analytic sample) had
sarcopenia and 78 were classified as sarcopenic at 3-year follow-up
(20.7% of sample available at 3-year follow-up) of whom, 33 were
incident cases (i.e. 42.3% of those with sarcopenia at 3-year follow-
up were new cases) (details not shown). After adjustment for socio-
demographic and health-related factors and BMI (Model 3), par-
ticipants in DP2 (‘Traditional British’) had increased odds of sar-
copenia at baseline (OR¼ 1.75 [95% CI: 1.06e2.90], p¼ 0.03) and 3-
year follow-up (OR ¼ 2.57, 95% CI: 1.26e5.26, p ¼ 0.01) compared
with those in DP3 (‘Low Butter’) (Table 2). Further adjustment for
lifestyle factors (Model 4) reduced the odds to non-significant at
baseline (OR ¼ 1.64, 0.98e2.77, p ¼ 0.06), but it remained signifi-
cant for prevalent sarcopenia at 3-year follow-up (OR ¼ 2.42,
1.15e5.09, p¼ 0.02). The associationwas not changed by adding the
retention variable (completing the study or not) in sensitivity
analysis (OR ¼ 2.45, 1.17e5.15, p ¼ 0.02) (details not shown).
Neither DP1 nor DP2 was associated with the risk of incident
sarcopenia at 3-year follow-up (Table 2).Table 1
Sarcopenia status in the Newcastle 85 þ Study participants by DPs.
Characteristic DP1: Low Red Meat
n ¼ 245
Sarcopenia status
Sarcopenia (baseline) % (n)
No 32.1 (179)
Yes 31.7 (46)
3-year prevalent sarcopenia % (n)
No 36.3 (107)
Yes 34.6 (27)
3-year incident sarcopenia % (n)
No 36.3 (97)
Yes 30.3 (10)
c2 test for categorical variables.
DPs, dietary patterns.
Please cite this article as: Granic A et al., Effects of dietary patterns and low
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follow-up) and 3-year incident sarcopenia in low (<1 g/kg aBW/d)
and good (1 g/kg aBW/d) protein intake groups
Similarly, we investigated the relationship between DPs and
prevalent and incident sarcopenia in the low (<1 g/kg aBW/d) and
good (1 g/kg aBW/d) protein intake groups (Table 3). In the low
protein intake group (n ¼ 332, 46% of analytic sample), 81 (21.5%)
and 34 (18.2%) had prevalent sarcopenia at baseline and 3-year
follow-up, respectively, and 14 (9.3%) had incident sarcopenia. In
the good protein intake group (n ¼ 390, 54% of analytic sample), 64
(19.8%) and 43 (23.8%) had prevalent sarcopenia (at baseline and 3-
year follow-up, respectively), and 19 (12.8%) had incident sarco-
penia. The differences in sarcopenia prevalence/incidence between
the groups were not significant (p  0.4) (details not shown).
DPs were not associated with odds of prevalent and incident
sarcopenia in the low protein intake group (Table 3). However, in
the good protein intake group, belonging to DP2 (‘Traditional
British’) was associated with the increased risk of prevalent sar-
copenia (at baseline: OR ¼ 2.14, 95% CI: 1.01e4.53, p ¼ 0.05; 3-year
follow-up: OR ¼ 5.45, 1.81e16.39, p ¼ 0.003 compared with DP3
(‘Low Butter’) after adjustment for all covariates. Adding the
retention variable in sensitivity analysis did not change the findings
(details not shown).3.4. Results for sensitivity analysis
Adding the interaction term between protein intake and phys-
ical activity to Model 4 did not attenuate the association between
prevalent sarcopenia and DP2 (OR¼ 2.36, 1.13e4.34, p¼ 0.02) in all
participants (details not shown). Using re-categorised BMI
(22e27 kg/m2 as a normal category) in the analysis with all par-
ticipants did not change the findings (e.g. 3-year prevalent sarco-
penia: 2.47, 1.17e5.02, p ¼ 0.02) (Appendix 2, Supplementary
Table 5).
Neither DP1 nor DP2 was significantly associated with the odds
of incident sarcopenia when sarcopenia cases were combined with
participants who died 1.5 years before 3-year follow-up (deaths
between wave 2 and 3, n ¼ 88) in the fully adjusted models.
Similar to the main results (Table 2), DP2 was not associated
with sarcopenia (prevalent or incident) if the low protein intake
group was defined as <0.8/g kg BW/d or <1 g/kg BW/d (Appendix 2,
Supplementary Tables 6 and 7, respectively). In the good protein
intake group defined as0.8 g/kg BW/d, the ORs for the association
between DP2 and sarcopenia (at baseline and 3-year follow-up)
remained raised, but were no longer significant in the fully
adjusted models (1.67, 0.96e2.92, p ¼ 0.7; 2.18, 1.00e3.81,DP2: Traditional British DP3: Low Butter p*
n ¼ 231 n ¼ 281
0.07
27.5 (153) 40.4 (225)
36.6 (53) 31.7 (46)
0.009
24.7 (73) 39.0 (115)
41.0 (32) 24.4 (19)
0.23
22.8 (61) 40.8 (109)
36.3 (12) 33.3 (11)
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Table 2
Association between DPs and odds of prevalent sarcopenia (at baseline and 3-year follow-up)a and 3-year incidentb sarcopenia (OR, 95% CI) in all participants.
Dietary patterns (n) Model 1 p Model 2 p Model 3 p Model 4 p
Sarcopenia (baseline)
n 702 657 655 645
DP1 1.26 (0.80e1.98) 0.32 1.34 (0.80e2.22) 0.27 1.38 (0.82e2.33) 0.23 1.31 (0.77e2.22) 0.32
DP2 1.70 (1.09e2.64) 0.02 1.74 (1.06e2.83) 0.03 1.75 (1.06e2.90) 0.03 1.64 (0.95e2.77) 0.06
DP3 (ref) 1 1 1 1
3-year prevalent sarcopenia
n 373 356 356 353
DP1 1.53 (0.80e2.91) 0.2 1.87 (0.92e3.82) 0.08 1.85 (0.89e3.84) 0.1 1.77 (0.84e3.74) 0.13
DP2 2.65 (1.40e5.03) 0.003 2.72 (1.35e5.46) 0.005 2.57 (1.26e5.26) 0.01 2.42 (1.15e5.09) 0.02
DP3 (ref) 1 1 1 1
3-year incident sarcopenia
n 300 288 288 286
DP1 1.02 (0.42e2.51) 0.96 1.23 (0.46e3.30) 0.68 1.19 (0.43e3.33) 0.73 1.05 (0.37e3.03) 0.92
DP2 1.95 (0.81e4.68) 0.13 1.98 (0.76e5.13) 0.16 1.83 (0.67e5.00) 0.24 1.67 (0.59e4.67) 0.33
DP3 (ref) 1 1 1 1
DP1 ‘Low Red Meat’; DP2 ‘Traditional British’; DP3 ‘Low Butter’.
OR, odds ratios; CI, confidence intervals; DPs, dietary patterns; ref, reference group.
Model 1 is unadjusted.
Model 2 is adjusted for socio-demographic factors (sex, social class, education) and body mass index.
Model 3 is additionally adjusted for health-related factors (cognitive status, depressive symptoms, total number of diseases, and total number of medication).
Model 4 is further adjusted for lifestyle factors (physical activity, smoking, and food energy).
a Sarcopenia status was determined using the European Working Group on Sarcopenia in Older People (EWGSOP) definition as described previously [4].
b Data from twowaves (2006/07 to 2009/10) were used for incidence sarcopenia. n indicated the number of participants with complete data (sarcopenia status (yes/no), DP
and risk factors).
Table 3
Association between DPs and odds of prevalent sarcopenia (at baseline and 3-year follow-up)a and 3-year incidentb sarcopenia (OR, 95% CI) in low and good protein intake
group.
Low protein intake group (<1 g/kg aBW/day)
Dietary patterns (n) Model 1 p Model 2 p Model 3 p Model 4 p
Sarcopenia (baseline)
n 376 360 356 354
DP1 1.19 (0.65e2.18) 0.57 1.18 (0.62e2.23) 0.62 1.13 (0.58e2.19) 0.72 1.00 (0.51e1.96) 0.99
DP2 1.64 (0.88e3.07) 0.12 1.49 (0.78e2.86) 0.23 1.47 (0.75e2.89) 0.26 1.20 (0.59e2.42) 0.62
DP3 (ref) 1 1 1 1
3-year prevalent sarcopenia
n 187 181 181 179
DP1 1.53 (0.80e2.91) 0.84 1.27 (0.48e3.42) 0.63 1.03 (0.36e2.93) 0.95 1.00 (0.34e2.90) 0.99
DP2 2.65 (1.40e5.03) 0.16 1.86 (0.70e4.96) 0.21 1.77 (0.64e4.89) 0.27 1.63 (0.56e4.81) 0.37
DP3 (ref) 1 1 1 1
3-year incident sarcopenia
n 150 145 145 144
DP1 0.93 (0.25e3.39) 0.91 1.12 (0.29e4.34) 0.87 0.88 (0.20e3.78) 0.86 0.91 (0.20e4.26) 0.91
DP2 1.25 (0.31e5.00) 0.75 1.29 (0.31e5.43) 0.73 1.39 (0.28e6.84) 0.69 1.39 (0.26e7.49) 0.70
DP3 (ref) 1 1 1 1
Good protein intake group (1 g/kg aBW/day)
Dietary patterns (n) Model 1 p Model 2 p Model 3 p Model 4 p
Sarcopenia (baseline)
n 324 310 302 301
DP1 1.32 (0.65e2.67) 0.45 1.59 (0.74e3.42) 0.24 1.87 (0.84e4.15) 0.23 1.84 (0.81e4.14) 0.14
DP2 1.75 (0.93e3.31) 0.08 1.80 (0.92e3.51) 0.08 1.93 (0.95e3.91) 0.07 2.14 (1.01e4.53) 0.047
DP3 (ref) 1 1 1 1
3-year prevalent sarcopenia
n 181 176 176 175
DP1 2.16 (0.89e5.27) 0.09 3.32 (1.26e8.74) 0.02 3.30 (1.17e9.29) 0.02 2.94 (0.98e8.87) 0.06
DP2 3.38 (1.40e8.16) 0.007 3.38 (1.36e8.40) 0.009 3.91 (1.48e10.29) 0.006 5.45 (1.81e16.36) 0.003
DP3 (ref) 1 1 1 1
3-year incident sarcopenia
n 149 144 144 143
DP1 1.17 (0.34e4.09) 0.81 1.69 (0.43e6.72) 0.45 1.32 (0.29e6.00) 0.72 0.74 (0.13e4.11) 0.73
DP2 2.71 (0.86e8.55) 0.09 2.52 (0.76e8.29) 0.13 2.45 (0.69e8.73) 0.17 3.44 (0.79e14.91) 0.10
DP3 (ref) 1 1 1 1
DP1 ‘Low Red Meat’; DP2 ‘Traditional British’; DP3 ‘Low Butter’.
OR, odds ratios; CI, confidence intervals; aBW, adjusted body weight; DPs, dietary patterns; ref, reference group.
Model 1 is unadjusted.
Model 2 is adjusted for socio-demographic factors (sex, social class, education).
Model 3 is additionally adjusted for health-related factors (cognitive status, depressive symptoms, total number of diseases, and total number of medication).
Model 4 is further adjusted for lifestyle factors (physical activity, smoking and food energy).
a Sarcopenia status was determined using the European Working Group on Sarcopenia in Older People (EWGSOP) definition as described previously [4].
b Data from twowaves (2006/07 to 2009/10) were used for incidence sarcopenia. n indicated the number of participants with complete data (sarcopenia status (yes/no), DP
and risk factors).
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prevalent sarcopenia in the good protein intake group defined as
1 g/kg BW/d (3.62, 1.33e9.88, p ¼ 0.01), confirming the results
from Table 2.
4. Discussion
In the present study, we investigated the risk of prevalent and
incident sarcopenia over 3 years in relation to DPs and protein
intake in community-dwelling adults aged85 living in North East
England, UK. In a model adjusted for key covariates, DP2 (‘Tradi-
tional British’), a group in which a higher proportion of people ate
butter, red meats/meat dishes, gravy, potatoes, vegetables, sweets/
desserts, and with the highest intake of fat and total energy, was
associated with a 2.4-fold increased risk of sarcopenia at 3-year
follow-up compared with DP3 (‘Low Butter’), a DP in which more
people ate unsaturated fat spreads and oils, and with the highest %E
from protein and starch. In addition, DP2 was associated with a 2.1-
fold and a 5.4-fold increased risk of prevalent sarcopenia at baseline
and 3-year follow-up, respectively in participants with good pro-
tein intake (1 g/kg aBW/d). DP2 was not associated with incident
sarcopenia over 3 years. These results add to a limited literature
reporting studies that used a ‘whole diet’ approach to under-
standing the role of nutrition in sarcopenia in older adults,
especially in the very old who are at higher risk of both malnutri-
tion [33,35,36] and sarcopenia [3e5].
Many observational studies have used a ‘single nutrient’
approach (e.g. protein or vitamin D) and elements of sarcopenia
(muscle mass, strength and function) to explore diet-muscle health
relationships [17,18,22e25,29,55] but there are few such studies in
very old adults [31]. The value of this approach in nutritional
research for sarcopenia is well established [56], but overlooks the
interactions between food groups and nutrients within diets, and
the likely complex, cumulative, synergistic and antagonistic in-
fluences of various nutrients/foods on aged muscle. Recent
consensus papers on the definition of sarcopenia [1,2] and the
recognition that sarcopenia is a major health problem that con-
tributes, fundamentally, to functional impairment and decline in
older adults, have stimulated interest in understanding the role of
modifiable factors such as (whole) diet in the aetiology, prevention
and management of sarcopenia. Several studies have used a ‘whole
diet’ approach and utilised either (a) pre-defined dietary indices
(based on the current knowledge about DPs that are associated
with better health) or (b) data-driven approaches using statistical
techniques to derive factors or clusters without any prior hypoth-
eses about diet-muscle function relationships to investigate the
impact of DPs on elements of sarcopenia [43,44,57e60]. In all,
higher adherence to a DP described as ‘Prudent diet’ (i.e. higher
intake of foods beneficial for health such as fish, fruits and vege-
tables) or Mediterranean-style diet (MED) was associated with
stronger grip, faster walking speed [57,58], and slower mobility
decline over 8e9 years in older adults aged 65 and over [59,60].
Using data from the Newcastle 85 þ Study, we have reported
recently that a DP high in fruits, fish, eggs, nuts, and whole grains
(but low in red/processed meats and potatoes) was associated with
stronger grip and faster TUG in very old adults compared with DPs
high in butter and red/processed meats [53].
We are aware of only a few studies [40e42; and reviewed in
43,44] that used a ‘whole diet’ approach to investigate the risk of
sarcopenia in adults aged 55, and none in the very old. This limits
the opportunity for direct comparisons of our findings with those
from other studies. All studies defined sarcopenia as loss of muscle
mass, and strength or function (i.e. using the EWGSOP or the Asian
Working Group for Sarcopenia algorithm), and derived DPs based
on FFQ [40e42]. In all studies, higher adherence to a healthy DPPlease cite this article as: Granic A et al., Effects of dietary patterns and low
study, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2019.01.009such asMED [40,42], Baltic Sea Diet (BSD) [42], ‘vegetable-fruits’ DP
and better diet quality (Diet Quality Index-International; DQI-I)
[41] was associated with lower risk of sarcopenia. Specifically, the
highest quartile of BSD (dietary index developed to account for
‘beneficial’ foods consumed routinely in the Nordic countries, such
as berries, salmon, rapeseed oil and dairy) was associated with a
67% lower risk of sarcopenia over 3-year follow-up in older women
[42]. Asian older menwith the highest diet quality had a 50% lower
risk of sarcopenia, and those in the highest ‘vegetable-fruit’ DP had
a 40% reduced risk [41] compared with those with lower adherence
scores. In the present study, membership of DP2 (‘Traditional
British’) characterised by a higher proportion of participants
consuming butter, red meats, gravy, potatoes, and sweets/desserts
substantially increased the risk of prevalent sarcopenia (by 2e5-
fold), compared with participants in DP3 (‘Low Butter’). This ef-
fect was apparent even in those with good protein intake (1 g/kg
aBW/d or 1 g/kg BW/d). DP3 had some elements of MED such as
the highest percentage (91%) of participants consuming unsatu-
rated fat spreads and oils (olive oil and other plant-based fats), and
the lowest intakes of SFA, cholesterol and %E from fat but the
highest %E from protein and starch, and the highest intake of fibre.
These dietary characteristics, in combinationwith high tomoderate
intake of other foods (red meat, soups, vegetable, and legumes;
Supplementary Table 1 and Supplementary Table 2) and lower
intake of less healthy foods (saturated fats spreads, gravy, and
sweets/desserts) may ameliorate progressive loss of muscle mass
and strength in the very old.
Multiple biological mechanism may have contributed to the
increased risk of sarcopenia in participants consuming the ‘Tradi-
tional British Diet’ (DP2), including the type and quality of dietary
fat consumed within DPs. Although the pathophysiology of sarco-
penia is complex and not completely explained, several processes
have been recognised to contribute to muscle wasting and loss of
function. These include (a) inflammation and production of
pro-inflammatory cytokines [61]; (b) imbalance between muscle
protein anabolism and catabolism, which may be due to anabolic
resistance [62], and (c) inter- and intramyocellular lipid accumu-
lation [63] affecting the quality of the aged muscle.
Dietary fats have a central role in muscle metabolism as an
important source of energy [64]; they are an integral part of myo-
cellular membranes [65], and have been shown to affect muscle
protein synthesis (MPS) [66]. The composition and amount of di-
etary fats influence inflammation [67] and insulin resistance [68]d
both mechanisms linked to sarcopenia. DP2 (compared to DP3) had
less favourable fatty acid intake and composition (e.g. the highest
intake of SFA, the lowest MUFA/SFA ratio), which may have exacer-
bated pro-catabolic processes (i.e. inflammation, insulin resistance,
oxidative stress) and increased fat deposition in the aged muscle.
Participants in DP3 (‘Low Butter’) had the highest %E from
protein and starch, whilst those in DP2 (‘Traditional British’) had
the highest %E from fat (SFA). However, it is still debatable whether
higher food intake and excess energy (quantity) or source of energy
(quality) is independently associated with sarcopenia (reviewed in
[56]). To date, there is a limited evidence about a direct relationship
between protein intake and sarcopenia (discussed in [17]), however
evidence is also emerging that supports the importance of higher
protein intake in combination with exercise (physical activity) to
combat anabolic resistance (and stimulate MPS)done of the
mechanisms implicated in sarcopenia in older adults [19,22,29].
Our results suggest that good protein intake may not be sufficient
to protect against sarcopenia if the combination of other foods in
diet are not favourable. Although the participants in DP2 (‘Tradi-
tional British’) were the least physically active, the main effect of
DP2 on the risk of sarcopenia remained independent after adjust-
ment for protein intake and physical activity interaction term.protein intake on sarcopenia risk in the very old: The Newcastle 85þ
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sarcopenia even when we combined participants who died 1.5
years before sarcopenia follow-up (wave 3) with incident sarco-
penia cases. Our study may have not been sufficiently powered to
detect such an association, and because of higher prevalence of
robust ‘survivors’ and pre-sarcopenia cases who did not transition
to sarcopenia during the period of study. In addition, participants
who died between baseline and follow-up may have done so
because of other health problems not related to sarcopenia.
This study has several limitations that need to be considered
when interpreting the results. The labels given to DPs may not
represent the most important (food) component or biological
aspect of the DP, and low or no intake of foods/nutrients may be as
important as those foods that were consumedmore frequently or in
larger amounts in relation to sarcopenia. The outcomes of cluster
analysis are dependent on the specific food groupings used and the
decisions taken when deriving such grouping may have influenced
the final DPs. Diet was assessed at baseline only and no information
about diet change over 3 years was available, although there is
some evidence of diet stability across the life course among British
older adults [69]. Other diet-related factors such as appetite loss,
social support, dietary knowledge, and access to food may have
affected participants’ food choices, and may have contributed to
Type I error in the logistic regression models. The lack of power in
data (especially in stratified analysis) may have resulted in Type II
error. The results may not be generalisable to other populations of
very old people with e.g. different ethnic backgrounds. The study
has several strengths, including its prospective design (a 3-year
follow-up for sarcopenia), validated dietary assessment [47],
adjustment for several known factors associated with sarcopenia
[3,4], and robustness of the results explored in sensitivity analysis.
In summary, using a data-driven approach and reported di-
etary intakes in community-dwelling older adults, we derived
three DPs that were associated with several health characteristics
including sarcopenia. Participants in the DP2 group (‘Traditional
British’), a diet high (i.e. high proportion of consumers) in butter,
red meats/meat dishes, gravy, potatoes, vegetables, sweets/des-
serts, and the highest intake of fat and total energy had an
increased risk of sarcopenia regardless of protein status compared
with DP3 (‘Low Butter’), a diet high in unsaturated fat spreads/
oils, fibre, and the highest %E from protein and starch. Findings
from this study need to be replicated in other cohorts of the very
old to understand the role of dietary patterns in sarcopenia onset
and management in populations at risk of functional decline and
dependence.
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